Search results

439 results found.

Statutes and regulations
/en/about-us/statutes-regulations
Several statutes and regulations govern RAMQ’s activities in the management of the health insurance and prescription drug insurance plans.
Notice - Regulation to amend the Regulation respecting the conditions of provision and payment of certain insured goods and services, June 27, 2014
/en/media/8186
Regulation respecting the conditions of provision and payment of certain insured goods and services, June 27, 2014
/en/media/8181
The regulation was amended and published on June 27, 2014.
Report wrongdoing (a person or situation)
/en/contact-us/report-wrongdoing-a-person-situation
You can report wrongdoing on the part of citizens, health professionals, organizations or report any situation in contravention of the agreements, statutes and regulations of the RAMQ.
Information distribution
/en/about-us/information-distribution
RAMQ publishes information and documents in keeping with the Regulation respecting the distribution of information and the protection of personal information.
Notice of alternative medication authorization, July 18, 2022
/en/media/13666
This notice was published on July 28, 2022.

Nutritional formula – infants and children (Althéra UK) and Nutritional formula – infants and children (Alfamino UK) replace:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, February 1 and 13, 2024
/en/media/16211
This notice was published on March 1, 2024.

Methadone hydrochloride in a concentration of 1 mg (effective February 1, 2024) and in a concentration of 5 mg (effective February 13, 2024).
Information documents
/en/about-us/information-documents
Find out about RAMQ’s services with respect to health insurance and prescription drug insurance and see the programs it administers.
Notice of alternative medication authorization, December 22, 2023
/en/media/16016
This notice was published on January 30, 2024.

Victoza^TM liraglutide (rupture) and Trulicity^TM dulaglutide (rupture) and Semaglutide replace Semaglutide (Ozempic).
Notice of alternative medication authorization, May 10, 2023
/en/media/14896
This notice was published on May 26, 2023.
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg

Search results

How did we do?